Home  »  Finance   »  Thinking About Buying GAN Limited Stock? Here’s ...

Thinking About Buying GAN Limited Stock? Here’s What You Need To Know.

GAN Limited (NASDAQ:GAN) shares, rose in value on Friday, 05/13/22, with the stock price up by 8.07% to the previous day’s close as strong demand from buyers drove the stock to $3.48.

Actively observing the price movement in the last trading, the stock closed the session at $3.22, falling within a range of $3.29 and $3.585. Referring to stock’s 52-week performance, its high was $18.48, and the low was $3.06. On the whole, GAN has fluctuated by -25.48% over the past month.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.

Sponsored

With the market capitalization of GAN Limited currently standing at about $141.18 million, investors are eagerly awaiting this quarter’s results, scheduled for Mar 23, 2022 – Mar 28, 2022. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be -$0.1, which is expected to increase to -$0.02 for fiscal year -$0.44 and then to about -$0.07 by fiscal year 2022. Data indicates that the EPS growth is expected to be 41.30% in 2022, while the next year’s EPS growth is forecast to be 84.10%.

Analysts have estimated the company’s revenue for the quarter at $35.26 million, with a low estimate of $33.77 million and a high estimate of $36.17 million. According to the average forecast, sales growth in current quarter could jump up 296.20%, compared to the corresponding quarter of last year. Wall Street analysts also predicted that in 2022, the company’s y-o-y revenues would reach $130 million, representing an increase of 269.70% from the revenues reported in the last year’s results.

Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that GAN’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium term indicators have put the stock in the category of 100% Sell while long term indicators on average have been pointing out that it is a 100% Sell.

The stock’s technical analysis shows that the PEG ratio is about 0, with the price of GAN currently trading nearly -11.44% and -24.17% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 37.01, while the 7-day volatility ratio is showing 12.61% which for the 30-day chart, stands at 8.21%. Furthermore, GAN Limited (GAN)’s beta value is 1.98, and its average true range (ATR) is 0.33.

Data on historical trading for GAN Limited (NASDAQ:GAN) indicates that the trading volumes over the past 10 days have averaged 0.6 million and over the past 3 months, they’ve averaged 580.23K. According to company’s latest data on outstanding shares, there are 42.21 million shares outstanding.

Nearly 4.20% of GAN Limited’s shares belong to company insiders and institutional investors own 52.10% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 2.54 million shares as on Dec 14, 2021, resulting in a short ratio of 2.79. According to the data, the short interest in GAN Limited (GAN) stood at 6.02% of shares outstanding as of Dec 14, 2021; the number of short shares registered in Nov 14, 2021 reached 2.41 million. The stock has fallen by -62.13% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the GAN stock heading into the next quarter.

Leave a Comment

Your email address will not be published.

Related Videos

Related Posts

NAVB

New Outlook On Pfizer Inc.

Pfizer Inc. (NYSE:PFE) price on Thursday, May 26, rose 1.69% above its previous day’s close as an upside momentum from buyers pushed the stock’s value

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam